US 8618152
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
granted A61KA61K38/00A61P
Quick answer
US patent 8618152 (Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12, A61P31/14